Annals of internal medicine · 1992
Screening hospital employees for measles immunity is more cost effective than blind immunization.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sellick J A, Longbine D, Schifeling R, Mylotte J M
Аннотация
OBJECTIVE: To examine alternative strategies in developing a cost-effective program to assure measles immunity among hospital employees.
DESIGN: Observational.
SETTING: Referral teaching hospital.
PARTICIPANTS: Eighteen hundred "established" hospital employees with potential patient contact and 630 newly hired hospital employees.
INTERVENTIONS: Established employees born after 1 January 1957 and all newly hired employees were screened for serologic evidence of measles immunity and immunized if necessary.
MEASUREMENTS: Cost analysis.
RESULTS: The cost of screening and directed immunization of established employees was $3.98 per employee compared with a potential cost of $10.03 to $42.80 per employee if all employees were "blindly" immunized with monovalent measles vaccine or trivalent mumps-measles-rubella vaccine. The cost of the screening and directed immunization of new employees was $2.42 per employee compared with potential costs of $8.30 to $39.34 per employee for blind immunization. These analyses assumed that varying percentages of employees would be able to produce documentation of having received a previous dose of vaccine or of having had measles.
CONCLUSIONS: In a large referral hospital, screening for measles immunity followed by directed immunization was considerably less expensive than immunizing all potentially susceptible employees.
DESIGN: Observational.
SETTING: Referral teaching hospital.
PARTICIPANTS: Eighteen hundred "established" hospital employees with potential patient contact and 630 newly hired hospital employees.
INTERVENTIONS: Established employees born after 1 January 1957 and all newly hired employees were screened for serologic evidence of measles immunity and immunized if necessary.
MEASUREMENTS: Cost analysis.
RESULTS: The cost of screening and directed immunization of established employees was $3.98 per employee compared with a potential cost of $10.03 to $42.80 per employee if all employees were "blindly" immunized with monovalent measles vaccine or trivalent mumps-measles-rubella vaccine. The cost of the screening and directed immunization of new employees was $2.42 per employee compared with potential costs of $8.30 to $39.34 per employee for blind immunization. These analyses assumed that varying percentages of employees would be able to produce documentation of having received a previous dose of vaccine or of having had measles.
CONCLUSIONS: In a large referral hospital, screening for measles immunity followed by directed immunization was considerably less expensive than immunizing all potentially susceptible employees.